Gilead Sciences GILD Insider Ownership

NASDAQ GILD

$156.10 +3.03 (+1.98%)

As of: Oct 20, 2026 · 1:56 PM EDT

Insider Holdings by Owner

1.31Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

0.096%

▼-0.0041% pp QoQ

Shares Held by Insiders

1.20Mn

filed for Sep 2026

▼-4.05% QoQ

Shares Outstanding

1.24Bn

1,243,000,000 shares

Direct Holdings

1.20Mn

Indirect: 0

Net Shares Traded (QoQ)

-50.43K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 11, 2026

Across the past 12 months, open-market trades by Gilead Sciences insiders were all sales, totaling $85.99 million (627.54K shares).

Gilead Sciences' open-market sales in the past 12 months came from 7 insiders; no insider bought.
The largest open-market sales of GILD in the past 12 months were by Daniel Patrick O'Day (Chairman & CEO), totaling $52.44 million (376.28K shares), most recently on October 1, 2026.
Apart from open-market trades, GILD insiders received 236.17K shares in stock awards, acquired 528.45K shares through option exercises and conversions and gave up 173.66K shares to cover taxes or exercise prices in the past 12 months.
Business Quant data puts insider holdings in GILD at 1.18Mn shares across insiders' latest Form 4 filings, down 5.25% from 1.25Mn shares at the end of Q2 2026 and down 6.23% from 1.26Mn shares at the end of Q3 2025.
Gilead Sciences insiders report no indirect holdings: all 1.18Mn shares are held directly.
Business Quant counts 18 insiders with holdings in Gilead Sciences stock, among the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Gilead Sciences' top three insider holders by shares held are Daniel Patrick O'Day (Chairman & CEO, 566.68K shares), Andrew D. Dickinson (Chief Financial Officer, 164.1K shares) and Johanna Mercier (Chief Comm & Corporate Aff Officer, 116.68K shares).
Daniel Patrick O'Day holds 47.98% of the combined insider position in Gilead Sciences.
Institutions owned 89.62% of GILD shares as of Q2 2026; insiders' latest Form 4 filings account for about 0.10%, leaving roughly 10.28% with other investors, including the public.
A total of 82 Form 4 filings with transactions in Gilead Sciences stock were made over the past 12 months, by 15 insiders.
Insider figures for GILD include Form 4 filings through October 2, 2026.

Form 4 Holdings

Insiders Holding GILD

Insiders 20

Shares held 1.31Mn

Of outstanding 0.105%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Daniel Patrick O'Day	Chairman Ceo	566,683	0	566,683	43.4%	02 Oct, 2026
2	Andrew D Dickinson	Chief Financial Officer	164,096	0	164,096	12.6%	16 Sep, 2026
3	Johanna Mercier	Chief Comm Corp Aff Officer	116,684	0	116,684	8.9%	16 Sep, 2026
4	Kevin E Lofton	Director	0	92,653	92,653	7.1%	04 May, 2023
5	Merdad Parsey	Chief Medical Officer	82,850	0	82,850	6.3%	11 Dec, 2024
6	Diane E. Wilfong	Interim Corp Controller Cao	46,259	0	46,259	3.5%	11 Sep, 2025
7	Deborah H Telman	Evp, Corporate Affairs Gc	43,676	0	43,676	3.3%	13 Nov, 2025
8	Sandra Patterson	Svp, Controllership	39,453	0	39,453	3.0%	12 Mar, 2025
9	Brett A Pletcher	Evp,Corp Affairs Gen Counsel	33,426	0	33,426	2.6%	13 Jun, 2022
10	Jacqueline K Barton	Director	27,202	0	27,202	2.1%	04 May, 2026
11	Dietmar Berger	Chief Medical Officer	19,522	0	19,522	1.5%	11 Sep, 2026
12	Harish Manwani	Director	15,015	0	15,015	1.1%	04 May, 2026
13	Javier Rodriguez	Director	13,364	0	13,364	1.0%	04 May, 2026
14	Anthony Welters	Director	12,894	0	12,894	1.0%	27 Aug, 2026
15	Jeffrey Bluestone	Director	10,066	0	10,066	0.8%	21 Aug, 2026
16	Wettan Keeley M Cain	Evp Gen Counsel, Legal Comp	8,759	0	8,759	0.7%	11 Sep, 2026
17	Sandra Horning	Director	6,293	0	6,293	0.5%	04 May, 2026
18	Ted W Love	Director	5,484	0	5,484	0.4%	04 May, 2026
19	Erin Burkhart	Svp, Controllership	1,455	0	1,455	0.1%	23 Sep, 2026
20	Kelly A. Kramer	Director	1,339	0	1,339	0.1%	01 Dec, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

6,079 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
01 Oct, 2026	Daniel Patrick O'Day	Chairman Ceo	Disposed S	12,000	$147.72	$1.77Mn	569,683	Direct
01 Oct, 2026	Daniel Patrick O'Day	Chairman Ceo	Disposed S	3,000	$148.63	$445.88K	566,683	Direct
22 Sep, 2026	Erin Burkhart	Svp, Controllership	Acquired M	2,223	—	—	2,223	Direct
22 Sep, 2026	Erin Burkhart	Svp, Controllership	Disposed F	768	$152.67	$117.25K	1,455	Direct
22 Sep, 2026	Erin Burkhart	Svp, Controllership	Disposed M	2,223	—	—	9,022	Direct
15 Sep, 2026	Johanna Mercier	Chief Comm Corp Aff Officer	Disposed S	1,600	$143.69	$229.91K	118,084	Direct
15 Sep, 2026	Andrew D Dickinson	Chief Financial Officer	Disposed S	3,000	$145.29	$435.87K	164,096	Direct
15 Sep, 2026	Johanna Mercier	Chief Comm Corp Aff Officer	Disposed S	800	$144.46	$115.57K	117,284	Direct
15 Sep, 2026	Johanna Mercier	Chief Comm Corp Aff Officer	Disposed S	600	$145.29	$87.17K	116,684	Direct
10 Sep, 2026	Johanna Mercier	Chief Comm Corp Aff Officer	Acquired M	2,797	—	—	121,031	Direct
10 Sep, 2026	Dietmar Berger	Chief Medical Officer	Acquired M	533	—	—	19,785	Direct
10 Sep, 2026	Wettan Keeley M Cain	Evp Gen Counsel, Legal Comp	Acquired M	590	—	—	9,044	Direct
10 Sep, 2026	Daniel Patrick O'Day	Chairman Ceo	Acquired M	8,780	—	—	585,913	Direct
10 Sep, 2026	Andrew D Dickinson	Chief Financial Officer	Acquired M	2,797	—	—	168,443	Direct
10 Sep, 2026	Andrew D Dickinson	Chief Financial Officer	Disposed F	1,347	$144.81	$195.06K	167,096	Direct
10 Sep, 2026	Daniel Patrick O'Day	Chairman Ceo	Disposed F	4,230	$144.81	$612.55K	581,683	Direct
10 Sep, 2026	Wettan Keeley M Cain	Evp Gen Counsel, Legal Comp	Disposed F	285	$144.81	$41.27K	8,759	Direct
10 Sep, 2026	Johanna Mercier	Chief Comm Corp Aff Officer	Disposed F	1,347	$144.81	$195.06K	119,684	Direct
10 Sep, 2026	Dietmar Berger	Chief Medical Officer	Disposed F	263	$144.81	$38.09K	19,522	Direct
10 Sep, 2026	Wettan Keeley M Cain	Evp Gen Counsel, Legal Comp	Disposed M	590	—	—	13,405	Direct

Showing 1 to 20 of 6,079 transactions